華星控股(08237.HK)發行可換股債券 料淨籌2,487萬元
華星控股(08237.HK)公布,公司與認購人訂立認購協議。據此,認購人同意認購,且公司同意發行本金額為2,512.8萬元的可換股債券,初步換股價為每股換股股份0.036元。
基於初步換股價為每股換股股份0.036元,於可換股債券所附換股權獲悉數行使時將配發及發行最多6.98億股換股股份,佔公司經擴大股本約16.67%。
發行可換股債券之所得款項淨額料約2,487萬元。公司擬將所得款項淨額用於贖回2020年可換股債券,餘下任何金額則用作集團一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.